The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the artificial intelligence in life sciences market in recent years?
The increasing interest in real-time remote patient monitoring (RPM) systems is expected to propel the growth of artificial intelligence in the life sciences market going forward. A remote patient monitoring system is a technology-driven healthcare solution designed to monitor patients’ health outside of traditional healthcare settings. AI in life sciences contributes significantly to remote patient monitoring by providing continuous, personalized, and data-driven insights that enable proactive healthcare management. For instance, in August 2023, according to a survey conducted by Livelink, a US-based digital healthcare company, clinicians’ use of remote patient monitoring (RPM) grew by 20% in 2021 to 81% in 2022, increasing by 305%. Therefore, the increasing interest in real-time remote patient monitoring (RPM) systems is driving the growth of artificial intelligence in the life sciences market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp
What is the projected market size of the artificial intelligence in life sciences industry, and how is it expected to grow?
The artificial intelligence in life sciences market size has grown exponentially in recent years. It will grow from $2.92 billion in 2024 to $3.61 billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increasing number of clinical trials, increasing adoption of ai in the domain of research and development, high emphasis on the development of precision medicine and personalized drugs.
The artificial intelligence in life sciences market size is expected to see exponential growth in the next few years. It will grow to $8.45 billion in 2029 at a compound annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be attributed to the increasing interest in real-time remote patient monitoring (rpm) systems, increasing demand for AI in drug discovery, the increasing adoption of ai in medical imaging analysis. Major trends in the forecast period include strategic partnership, product innovations, technological advancements, investments, research and developments.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13587&type=smp
Who are the key players driving competition in the artificial intelligence in life sciences market?
Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.
What key trends are expected to drive the artificial intelligence in emotion recognition market during the forecast period?
Major companies operating in the artificial intelligence in the life sciences market are focusing on innovative products with technological advancements, such as drug discovery software, to sustain their position in the market. Drug discovery software refers to a category of computer programs and applications designed to assist pharmaceutical and biotechnology researchers in the process of discovering new drugs. For instance, in December 2023, Merck, a Germany-based science and technology company, unveiled AIDDISON, a groundbreaking drug discovery software. As the first-ever of its kind, it connects virtual molecule design with real-world manufacturability, using generative AI, machine learning, and computer-aided drug design. AIDDISON efficiently identifies drug candidates from vast possibilities, considering crucial properties like non-toxicity and solubility. Its ability to bridge the gap between virtual molecule design and real-world manufacturability is a notable application of artificial intelligence in the life sciences sector.
Which key geographies are driving the growth of the artificial intelligence in life sciences market?
North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
What are the key segments driving growth in the artificial intelligence in life sciences market?
The artificial intelligence in life sciences market covered in this report is segmented –
1) By Offering: Software, Hardware, Services
2) By Deployment: On-Premises, Cloud-Based
3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision And Personalized Medicine, Patient Monitoring
Subsegments:
1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)
2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies
3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13587
How is the artificial intelligence in life sciences market defined, and what are its core characteristics?
Artificial intelligence (AI) in life sciences refers to the application of AI technologies and techniques in various domains within the life sciences industry. The integration of AI in life sciences aims to enhance and expedite processes, improve decision-making, and generate valuable insights from complex data sets.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
